The global capnography devices market size reached US$ 407.7 Million in 2023. Looking forward, the publisher expects the market to reach US$ 659.6 Million by 2032, exhibiting a growth rate (CAGR) of 5.49% during 2023-2032.
Capnography devices refer to various medical equipment that are used for measuring the amount of carbon dioxide (CO2) present in the patient’s bloodstream. They measure the inhaled and exhaled concentration of CO2 in the body. The devices are used for patients undergoing anesthesia to ensure that they are receiving ample oxygen throughout the surgical procedure. These devices are commonly available in handheld, standalone and multi-parameter variants based on main-, side- and micro-stream technologies. They also aid in diagnosing the cause of respiratory distress, providing real-time feedback on treatment effects and detecting shocks.
The increasing prevalence of respiratory and chronic obstructive pulmonary diseases (COPD), such as pulmonary embolism and asthma, is one of the key factors driving the growth of the market. These devices are also being used for monitoring patients under intensive care who are suffering from the coronavirus disease (COVID-19). Furthermore, the rising geriatric population, which is more susceptible to lung disorders, is also providing driving the market growth. Capnography devices are widely being used for operative and post-operative care of patients and are commonly used in operation, recovery and critical rooms, wards and ambulances.
Various product innovations, such as the development of technologically advanced devices that offer ease-of-connection, convenient sterilization and enable accurate monitoring of non-intubated substances, are acting as another growth-inducing factor. The market is further driven by the launch of variants that are integrated with photodetectors, molecular correlation spectroscopy and miniaturized multi-gas monitors that are highly accurate and have an adjustable flow rate. Other factors, including significant improvements in the healthcare infrastructure, along with the development of portable and point-of-care (POC) capnography devices, are projected to create a positive outlook for the market.
2. What is the expected growth rate of the global capnography devices market during 2024-2032?
3. What are the key factors driving the global capnography devices market?
4. What has been the impact of COVID-19 on the global capnography devices market?
5. What is the breakup of the global capnography devices market based on the product?
6. What is the breakup of the global capnography devices market based on the product type?
7. What is the breakup of the global capnography devices market based on technology?
8. What is the breakup of the global capnography devices market based on the application?
9. What is the breakup of the global capnography devices market based on the end-user?
10. What are the key regions in the global capnography devices market?
11. Who are the key players/companies in the global capnography devices market?
Capnography devices refer to various medical equipment that are used for measuring the amount of carbon dioxide (CO2) present in the patient’s bloodstream. They measure the inhaled and exhaled concentration of CO2 in the body. The devices are used for patients undergoing anesthesia to ensure that they are receiving ample oxygen throughout the surgical procedure. These devices are commonly available in handheld, standalone and multi-parameter variants based on main-, side- and micro-stream technologies. They also aid in diagnosing the cause of respiratory distress, providing real-time feedback on treatment effects and detecting shocks.
The increasing prevalence of respiratory and chronic obstructive pulmonary diseases (COPD), such as pulmonary embolism and asthma, is one of the key factors driving the growth of the market. These devices are also being used for monitoring patients under intensive care who are suffering from the coronavirus disease (COVID-19). Furthermore, the rising geriatric population, which is more susceptible to lung disorders, is also providing driving the market growth. Capnography devices are widely being used for operative and post-operative care of patients and are commonly used in operation, recovery and critical rooms, wards and ambulances.
Various product innovations, such as the development of technologically advanced devices that offer ease-of-connection, convenient sterilization and enable accurate monitoring of non-intubated substances, are acting as another growth-inducing factor. The market is further driven by the launch of variants that are integrated with photodetectors, molecular correlation spectroscopy and miniaturized multi-gas monitors that are highly accurate and have an adjustable flow rate. Other factors, including significant improvements in the healthcare infrastructure, along with the development of portable and point-of-care (POC) capnography devices, are projected to create a positive outlook for the market.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global capnography devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, product type, technology, application and end-user.Breakup by Product:
- Capnometers
- Accessories
Breakup by Product Type:
- Handheld
- Conventional
Breakup by Technology:
- Main-stream
- Side-stream
- Micro-stream
Breakup by Application:
- Trauma and Emergency Care
- Cardiac Care
- Respiratory Monitoring
- Others
Breakup by End-User:
- Hospitals and Clinics
- Ambulatory Surgery Centers (ASCs)
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Becton, Dickinson and Company (BD), Burtons Medical Equipment Ltd., Opto Cardiac Care Limited (Criticare Technologies Inc.), FUTEK Advanced Sensor Technology, Inc., DiaMedica Therapeutics, Inc. (DMAC), Drägerwerk AG, EDAN Instruments Inc., Hill-Rom Services Inc., Infinium Medical, Inc., Koninklijke Philips N.V., Masimo Corporation, Medtronic Inc., Nihon Kohden Corporation, Nonin Medical Inc., Smiths Medical MD, Inc. and Zoe Medical Incorporated. etc.Key Questions Answered in This Report
1. What was the size of the global capnography devices market in 2023?2. What is the expected growth rate of the global capnography devices market during 2024-2032?
3. What are the key factors driving the global capnography devices market?
4. What has been the impact of COVID-19 on the global capnography devices market?
5. What is the breakup of the global capnography devices market based on the product?
6. What is the breakup of the global capnography devices market based on the product type?
7. What is the breakup of the global capnography devices market based on technology?
8. What is the breakup of the global capnography devices market based on the application?
9. What is the breakup of the global capnography devices market based on the end-user?
10. What are the key regions in the global capnography devices market?
11. Who are the key players/companies in the global capnography devices market?
Table of Contents
1 Preface3 Executive Summary13 Value Chain Analysis15 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Capnography Devices Market
6 Market Breakup by Product
7 Market Breakup by Product Type
8 Market Breakup by Technology
9 Market Breakup by Application
10 Market Breakup by End-User
11 Market Breakup by Region
12 SWOT Analysis
14 Porters Five Forces Analysis
16 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Becton
- Dickinson
- Company (BD)
- Burtons Medical Equipment Ltd.
- Opto Cardiac Care Limited (Criticare Technologies Inc.)
- FUTEK Advanced Sensor Technology Inc.
- DiaMedica Therapeutics Inc. (DMAC)
- Drägerwerk AG
- EDAN Instruments Inc.
- Hill-Rom Services Inc.
- Infinium Medical Inc.
- Koninklijke Philips N.V.
- Masimo Corporation
- Medtronic Inc.
- Nihon Kohden Corporation
- Nonin Medical Inc.
- Smiths Medical MD Inc.
- Zoe Medical Incorporated
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 148 |
Published | August 2024 |
Forecast Period | 2023 - 2032 |
Estimated Market Value ( USD | $ 407.7 Million |
Forecasted Market Value ( USD | $ 659.6 Million |
Compound Annual Growth Rate | 5.5% |
Regions Covered | Global |
No. of Companies Mentioned | 18 |